By combining unique chemical discovery platform with “fate determinant” genomic database, iRegene scoops new chemicals to trig specific trandifferentiation process without genomic modification.
iRegene Therapeutics focuses on new generation of “Chemical guided Allogeneic Cell Therapy” and aims to play an essential role in curing "incurable" diseases, such as degenerative disorders.
iRegene Therapeutics focuses on new generation of chemical defined cell therapy and aims to
play an essential role in curing "incurable" diseases, such as the Parkinson’s disease and
blindness. As an expert in chemical derived regeneration, iRegene chemical induce system
enables easy generation of human cell-types with high purity.
As a novel therapeutic approach, cell therapy is tremendously active in recent years. However, there remains many technical issues which impede cell-based therapies toward clinical application. One of the common problems is how to achieve highly efficient and accurate cell-type-transformation. Some widely used methods use viral or non-viral vectors to modify the genome，which cause the safety concerns especially for the long-lasting cell types.